| Aboriginal (n = 1641) | TSI (n = 968) | Overall (N = 2609) | ||
---|---|---|---|---|---|
 | Mean or No. | 95% CI | Mean or No. | 95% CI | Mean or No. |
Female | N = 881 | Â | N = 471 | Â | Â |
Age, years (SD) | 37.4(15.5) | 36.4- 38.4 | 38.3 (16.0) | 36.9-39.75 | 37.7 (15.7) |
WC, cm (SD) * | 92.2 (16.5) | 91.1- 93.3 | 103.6 (15.6) | 102.1-105.1 | 96.2 (17.4) |
BMI, kg/m2 (SD)* | 25.5 (6.6) | 25.2-25.9 | 31.0 (6.7) | 30.5- 31.4 | 27.6 (7.1) |
SBP, mmHg (SD)* | 125.5 (17.0) | 124.1-126. 9 | 130.3 (16.1) | 128.4-132.3 | 127.2 (21.3) |
DBP, mmHg (SD)* | 69.7 (13.5) | 68.8-70.6 | 67.8 (12.2) | 66.7-68.9 | 69.0 (13.1) |
T Chol, mmol/L (SD) | 4.8 (1.0) | 4.7- 4.82 | 4.8 (1.0) | 4.75- 4.9 | 4.8 (1.0) |
HDL, mmol/L (SD) * | 1.16 (0.3) | 1.14-1.18 | 1.11 (0.2) | 1.09-1.13 | 1.1 (0.3) |
GGT, U/L (SD) * | 39.2 (47.1) | 36.0-42.4 | 27.2 (21.1) | 25.3-29.1 | 35.0 (40.4) |
FPG, mmol/L (SD)* | 5.5 (2.5) | 5.4-5.7 | 6.2 (3.1) | 5.9-6.5 | 5.8 (2.7) |
Trigs, mmol/L (SD)‡* | 1.7 (1.2) | 1.6-1.73 | 1.5 (1.1) | 1.4- 1.6 | 1.6 (1.1) |
Abdominal obesity †(%)* | |||||
   Normal | 205 (23.6) | 20.5-26.1 | 43 (9.1) | 6.5-11.7 | 248 (18.5) |
   Overweight | 158 (18.2) | 15.4-20.4 | 40 (8.5) | 6.0-11.0 | 198 (14.8) |
   Obesity | 507 (58.3) | 55.5-62.1 | 388 (82.4) | 78.9-85.8 | 895 (66.7) |
BMI (%)* | Â | Â | Â | Â | Â |
   <25 | 405 (46.0) | 42.7-49.3 | 76 (16.1) | 12.8-19.5 | 481 (35.6) |
   25-30 | 237 (26.9) | 24.0-29.8 | 109 (23.1) | 19.3-27.0 | 346 (25.6) |
   30+ | 239 (27.1) | 24.2-30.1 | 286 (60.7) | 48.8-55.1 | 525 (38.8) |
Smokers (%)* | 490 (56.0) | 52.7-59.3 | 211 (44.8) | 40.3-49.3 | 701 (52.1) |
Drinking (%) * | 526 (62.4) | 59.2-65.7 | 233 (51.1) | 46.5-55.7 | 759 (58.5) |
Risky drinking †(%) * | 356 (67.7) | 63.7-71.7 | 112 (48.1) | 41.6-54.5 | 468 (61.7) |
Physically active †(%)* | 164 (18.6) | 16.0-21.2 | 117 (24.8) | 20.9-28.7 | 281 (20.8) |
GGT ≥50 U/L (%) * | 181 (21.2) | 18.4-23.9 | 36 (7.8) | 5.4-10.3 | 217 (16.5) |
Diabetes (%)* | 114 (12.9 ) | 10.7-15.2 | 107 (22.7) | 18.9-26.5 | 221 (16.4) |
Metabolic syndrome †(%) * | 353 (40.1) | 36.9-43.4 | 246 (52.2) | 47.7-56.7 | 595 (44.3) |
Adverse MR cluster profile †(%) | 268 (34.3) | 31.0-37.6 | 171(37.7) | 33.2-42.1 | 439 (35.6) |
Male | N = 760 | Â | N = 497 | Â | Â |
Age, years (SD) | 36.6(14.9) | 35.5-37.7 | 37.5 (15.2) | 36.2-38. 9 | 37.0 (15.1) |
WC, cm (SD) * | 89.7 (14.6) | 88.7-90.8 | 100.7 (15.0) | 99.4-102.1 | 94.1 (15.7) |
BMI, kg/m2 (SD)* | 24.5 (5.6) | 24.1-24.9 | 29.8 (5.8) | 29.2-30.3 | 26.6 (6.2) |
SBP, mmHg (SD)* | 130.8 (19.5) | 129.6-132.0 | 136.3 (19.1) | 134.8-137.7 | 130.0 (16.9) |
DBP, mmHg (SD) | 74.2 (13.8) | 73.2-75.2 | 73.4 (13.1) | 72.3-74.6 | 73.9 (13.5) |
T Chol, mmol/L (SD)* | 5.0 (1.1) | 4.9- 5.04 | 5.2 (1.0) | 5.1- 5.3 | 5.1 (1.1) |
HDL, mmol/L (SD) * | 1.2 (0.4) | 1.17-1.22 | 1.1 (0.3) | 1.102-1.15 | 1.2 (0.3) |
GGT, U/L (SD) * | 71.0 (85.6) | 64.8-77.3 | 46.0 (49.2) | 41.6-50.4 | 61.0 (74.2) |
FPG, mmol/L (SD)* | 5.4 (2.1) | 5.2-5.5 | 6.0 (2.8) | 5.7-6.2 | 5.6 (2.4) |
Trigs, mmol/L (SD)‡* | 2.1 (1.9) | 2.0- 2.2 | 1.9 (1.4) | 1.7-2.0 | 2.0 (1.8) |
Abdominal obesity †(%)* |  |  |  |  |  |
   Normal | 486 (64.1) | 60.5-67.4 | 156 (31.5) | 27.3-35.5 | 642 (51.2) |
   Overweight | 130 (17.2) | 14.4-19.9 | 111 (22.4) | 18.7-26.0 | 241 (19.2) |
   Obesity | 142(18.7) | 16.2-21.7 | 228 (46.1) | 78.9-85.8 | 370 (29.5) |
BMI (%)* | Â | Â | Â | Â | Â |
   <25 | 856 (52.2) | 49.7-54.6 | 178 (18.4) | 15.9-20.8 | 1034 (39.6) |
   25-30 | 417 (25.4) | 23.3-27.5 | 287 (29.7) | 26.8-32.5 | 704 (27.0) |
   30+ | 368 (22.4) | 20.4-24.4 | 503 (52.0) | 48.8-55.1 | 871 (33.4) |
Smokers (%)* | 516 (68.8) | 65.5-72.1 | 274 (55.5) | 51.1-59.9 | 1491 (57.6) |
Drinking (%) * | 607 (82.3 ) | 79.5-85.0 | 369 (75.3) | 71.5-79.1 | 976 (79.5) |
Risky drinking †(%) * | 485 (79.9) | 76.7-83.1 | 230 (62.3) | 57.4-67.3 | 715 (73.3) |
Physically active †(%)* | 163 (21.4) | 18.5-24.4 | 168 (33.8) | 29.6-38.0 | 331 (26.3) |
GGT ≥50 U/L (%) * | 312 (42.7) | 39.1-46.3 | 128 (26.2) | 22.3-30.1 | 440 (36.1) |
Diabetes (%)* | 72 (9.5) | 7.3-11.6 | 83 (16.7) | 13.4-20.0 | 155 (12.3) |
Metabolic syndrome †(%) * | 199 (26.2) | 23.1-29.3 | 232 (46.7) | 42.3-56.1 | 431 (34.3) |
Adverse MR cluster profile †(%) * | 275 (40.8) | 37.1-44.5 | 241 (50.6) | 46.1-55.1 | 516 (44.9) |